Search Medical Condition
Please enter condition
Please choose location from dropdown

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1094) clinical trials

People with Alzheimer ’s disease are asked to participate in a research study being conducted by New York University School of Medicine.  

Phase N/A

The purpose of this study is to determine the effects of CNP520 on cognition, global clinical status, and underlying AD pathology, as well as the safety of CNP520, in people at risk for the onset of clinical symptoms of AD based on their age, APOE genotype and elevated amyloid.

Phase

The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.

Phase

A study to evaluate the safety and tolerability of SEP363856 in subjects with Parkinson's Disease Psychosis.  

Phase

The primary objective of the study is to evaluate the efficacy of AGB101 on slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with mild cognitive impairment due to Alzheimer's Disease (MCI due to AD) ...

Phase

Have you or a loved one been diagnosed with Alzheimer's Disease? You may be interested in a research study at Advanced Clinical Research.  

Phase N/A

Study participation will last about a year.   Following a screening period of up to 6 weeks, qualified participants will be randomly assigned to the oral investigational medication, C0R388, or a placebo (an inactive substance).   During the treatment period, the participants will visit the research center 9 times over a 48 ...

Phase

The purpose of this study is to understand whether the drug, pimavanserin, improves symptoms of hallucinations and/or delusions experienced in people with dementia.

Phase

Clinical research study of an investigational drug that may help slow or stop memory loss in people with early stages of Alzheimer's disease.  

Phase